Lipocine Inc (LPCN)
4.44
-0.36
(-7.50%)
USD |
NASDAQ |
Apr 24, 16:00
4.455
+0.02
(+0.34%)
After-Hours: 20:00
Lipocine Cash from Operations (TTM): -11.87M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -11.87M |
September 30, 2023 | -11.68M |
June 30, 2023 | -12.27M |
March 31, 2023 | -12.01M |
December 31, 2022 | -11.97M |
September 30, 2022 | -1.135M |
June 30, 2022 | -4.918M |
March 31, 2022 | -4.235M |
December 31, 2021 | -4.411M |
September 30, 2021 | -17.09M |
June 30, 2021 | -14.27M |
March 31, 2021 | -15.99M |
December 31, 2020 | -15.30M |
September 30, 2020 | -14.93M |
June 30, 2020 | -13.56M |
March 31, 2020 | -12.04M |
December 31, 2019 | -11.67M |
September 30, 2019 | -10.59M |
June 30, 2019 | -11.15M |
March 31, 2019 | -11.34M |
December 31, 2018 | -12.08M |
September 30, 2018 | -14.14M |
June 30, 2018 | -15.35M |
Date | Value |
---|---|
March 31, 2018 | -17.31M |
December 31, 2017 | -16.70M |
September 30, 2017 | -14.95M |
June 30, 2017 | -14.44M |
March 31, 2017 | -14.91M |
December 31, 2016 | -18.28M |
September 30, 2016 | -18.65M |
June 30, 2016 | -20.15M |
March 31, 2016 | -18.84M |
December 31, 2015 | -15.36M |
September 30, 2015 | -16.41M |
June 30, 2015 | -13.33M |
March 31, 2015 | -17.11M |
December 31, 2014 | -17.30M |
September 30, 2014 | -17.45M |
June 30, 2014 | -19.45M |
March 31, 2014 | -11.81M |
December 31, 2013 | -8.588M |
September 30, 2013 | -2.399M |
June 30, 2013 | -0.0034M |
March 31, 2013 | -0.0579M |
December 31, 2012 | -0.0629M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-17.09M
Minimum
Sep 2021
-1.135M
Maximum
Sep 2022
-11.11M
Average
-11.97M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
Alpine Immune Sciences Inc | -79.01M |
Eliem Therapeutics Inc | -20.60M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |